用于治疗细菌感染的新型三环化合物。
Novel Tricyclic Compounds for Treating Bacterial Infections.
作者信息
Sabnis Ram W
机构信息
Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Atlanta, Georgia 30309, United States.
出版信息
ACS Med Chem Lett. 2025 May 21;16(6):972-973. doi: 10.1021/acsmedchemlett.5c00289. eCollection 2025 Jun 12.
Abstract
Provided herein are novel tricyclic compounds, pharmaceutical compositions, use of such compounds in treating bacterial infections, and processes for preparing such compounds.
摘要
本文提供了新型三环化合物、药物组合物、此类化合物在治疗细菌感染中的用途以及制备此类化合物的方法。
相似文献
1
Novel Tricyclic Compounds for Treating Bacterial Infections.
ACS Med Chem Lett. 2025 May 21;16(6):972-973. doi: 10.1021/acsmedchemlett.5c00289. eCollection 2025 Jun 12.
2
Novel Papain-Like Protease Inhibitors for Treating Viral Infections, in Particular Coronavirus Infections.
ACS Med Chem Lett. 2024 Oct 14;15(11):1802-1803. doi: 10.1021/acsmedchemlett.4c00474. eCollection 2024 Nov 14.
3
Novel Papain-Like Protease Inhibitors for Treating Viral Infections, in particular, Coronavirus Infections.
ACS Med Chem Lett. 2024 Jul 23;15(8):1186-1187. doi: 10.1021/acsmedchemlett.4c00331. eCollection 2024 Aug 8.
4
Pyrrolidines as Main Protease Inhibitors for Treating Viral Infections, in Particular, Coronavirus Infections.
ACS Med Chem Lett. 2024 Nov 15;15(12):2097-2098. doi: 10.1021/acsmedchemlett.4c00553. eCollection 2024 Dec 12.
5
Novel Ergoline Compounds as 5-HT2A Agonists for Treating Mood Disorders Such as Depressive Disorders and Bipolar Disorders.
ACS Med Chem Lett. 2024 Dec 20;16(1):32-33. doi: 10.1021/acsmedchemlett.4c00593. eCollection 2025 Jan 9.
6
Novel Tryptamine Compounds as 5-HT2A Agonists for Treating Mood Disorders such as Depressive Disorders and Bipolar Disorders.
ACS Med Chem Lett. 2025 Feb 13;16(3):373-374. doi: 10.1021/acsmedchemlett.5c00047. eCollection 2025 Mar 13.
7
Novel Compounds as CDK2 Inhibitors for Treating Cancer.
ACS Med Chem Lett. 2024 Dec 10;16(1):14-15. doi: 10.1021/acsmedchemlett.4c00574. eCollection 2025 Jan 9.
8
Novel Compounds as 5-HT2A Receptor Modulators for Treating Psychiatric and Neurological Disorders.
ACS Med Chem Lett. 2025 Mar 13;16(4):508-509. doi: 10.1021/acsmedchemlett.5c00093. eCollection 2025 Apr 10.
9
Novel Aryl Hydrocarbon Receptor Agonist Compounds for Treating Psoriasis and Atopic Dermatitis.
ACS Med Chem Lett. 2025 May 16;16(6):935-936. doi: 10.1021/acsmedchemlett.5c00267. eCollection 2025 Jun 12.
10
Novel Compounds as NLRP3 Inhibitors for Treating Cardiovascular Diseases.
ACS Med Chem Lett. 2024 Jul 11;15(8):1184-1185. doi: 10.1021/acsmedchemlett.4c00304. eCollection 2024 Aug 8.
本文引用的文献
1
Recent Advances in Immunotherapeutic and Vaccine-Based Approaches for the Treatment of Drug-Resistant Bacterial Infections.
ACS Infect Dis. 2025 Jun 13;11(6):1366-1402. doi: 10.1021/acsinfecdis.5c00001. Epub 2025 May 2.
2
Design of Short Peptides for the Reduction of Silver Ions and Stabilization of Nanocomposites in Combating Bacterial Infections.
Chembiochem. 2025 Jun 3;26(11):e202500122. doi: 10.1002/cbic.202500122. Epub 2025 Apr 4.
3
Harnessing Cyclic di-GMP Signaling: A Strategic Approach to Combat Bacterial Biofilm-Associated Chronic Infections.
Curr Microbiol. 2025 Feb 5;82(3):118. doi: 10.1007/s00284-025-04091-7.
4
Immune checkpoint blockade in experimental bacterial infections.
J Infect. 2025 Feb;90(2):106391. doi: 10.1016/j.jinf.2024.106391. Epub 2025 Jan 3.
5
Metabolomics in the Diagnosis of Bacterial Infections.
Clin Chim Acta. 2025 Jan 15;565:120020. doi: 10.1016/j.cca.2024.120020. Epub 2024 Nov 1.
6
Novel Oxopyrido[1,2-]pyrimidine Compounds for Treating Bacterial Infection.
ACS Med Chem Lett. 2021 Feb 17;12(3):324-325. doi: 10.1021/acsmedchemlett.1c00077. eCollection 2021 Mar 11.
Zotero 插件